Discovery of Urinary Biomarker: Urine Amyloid Beta as a Non-Invasive Biomarker for Early Alzheimer’s Disease and Cognitive Impairment - A Study of 24 Patients with Cognitive Decline
Alzheimer's disease (AD) is a progressive neurodegenerative illness characterized by the accumulation of tau tangles and amyloid beta (A) plaques in the brain, ultimately leading to dementia and cognitive impairment [1-2].
Authors
- Kris Ke Shyang See
Publication Details
- Journal
- Journal of Clinical Practice and Medical Case Report.
- Published
- 2024-11-08
- DOI
- https://doi.org/10.52793/jcpmcr.2024.1(2)-13
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39